Clinical Trial Update: Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing P-Gemox versus EPOCH as first-line chemotherapy for early-stage Extranodal NK/T-cell lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• PREDNISONE (Prednisone)
• Pegaspargase (pegaspargase)
• Vincristine (vincristine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lymphoma, Extranodal NK-T-Cell | Phase 3 | Status: TERMINATED